VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 187 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,035 | -60.0% | 19,507 | -38.2% | 0.04% | -60.0% |
Q1 2024 | $2,588 | +155.5% | 31,563 | -42.1% | 0.09% | +150.0% |
Q4 2023 | $1,013 | +47.9% | 54,469 | -11.9% | 0.04% | +33.3% |
Q3 2023 | $685 | -99.9% | 61,819 | 0.0% | 0.03% | -25.0% |
Q2 2023 | $1,002,086 | +117240.3% | 61,819 | +20.4% | 0.04% | +12.5% |
Q1 2023 | $854 | +3.4% | 51,328 | -41.6% | 0.03% | -3.0% |
Q4 2022 | $826 | – | 87,842 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |